Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Women with high androgen levels may have more severe COVID-19 symptoms.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.